Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme

Li-Jen Su; Ching-Wei Chang; Yu-Chung Wu; Kuang-Chi Chen; Chien-Ju Lin; Shu-Ching Liang; Chi-Hung Lin; Whang-Peng, Jacqueline; Shih-Lan Hsu; Chen-Hsin Chen; Chi-Ying F Huang
January 2007
BMC Genomics;2007, Vol. 8, p1
Academic Journal
Background: The development of microarrays permits us to monitor transcriptomes on a genome-wide scale. To validate microarray measurements, quantitative-real time-reverse transcription PCR (Q-RT-PCR) is one of the most robust and commonly used approaches. The new challenge in gene quantification analysis is how to explicitly incorporate statistical estimation in such studies. In the realm of statistical analysis, the various available methods of the probe level normalization for microarray analysis may result in distinctly different target selections and variation in the scores for the correlation between microarray and Q-RT-PCR. Moreover, it remains a major challenge to identify a proper internal control for Q-RT-PCR when confirming microarray measurements. Results: Sixty-six Affymetrix microarray slides using lung adenocarcinoma tissue RNAs were analyzed by a statistical re-sampling method in order to detect genes with minimal variation in gene expression. By this approach, we identified DDX5 as a novel internal control for Q-RT-PCR. Twenty-three genes, which were differentially expressed between adjacent normal and tumor samples, were selected and analyzed using 24 paired lung adenocarcinoma samples by Q-RT-PCR using two internal controls, DDX5 and GAPDH. The percentage correlation between Q-RT-PCR and microarray were 70% and 48% by using DDX5 and GAPDH as internal controls, respectively. Conclusion: Together, these quantification strategies for Q-RT-PCR data processing procedure, which focused on minimal variation, ought to significantly facilitate internal control evaluation and selection for Q-RT-PCR when corroborating microarray data.


Related Articles

  • Normalization of array-CGH data: influence of copy number imbalances. Staaf, Johan; Jünsson, Güran; Ringnér9, Markus; Vallon-Christersson, Johan // BMC Genomics;2007, Vol. 8, p382 

    Background: High-resolution microarray-based comparative genomic hybridization (CGH) techniques have successfully been applied to study copy number imbalances in a number of settings such as the analysis of cancer genomes. For normalization of array-CGH data, methods initially developed for gene...

  • Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. Hongying Jiang; Youping Deng; Huann-Sheng Chen; Lin Tao; Qiuying Sha; Chen, Jun; Chung-Jui Tsai; Shuanglin Zhang // BMC Bioinformatics;2004, Vol. 5, p81 

    Background: Due to the high cost and low reproducibility of many microarray experiments, it is not surprising to find a limited number of patient samples in each study, and very few common identified marker genes among different studies involving patients with the same disease. Therefore, it is...

  • Integration of breast cancer gene signatures based on graph centrality. Jianxin Wang; Gang Chen; Min Li; Yi Pan // BMC Systems Biology;2011 Supplement 3, Vol. 5 Issue Suppl 3, p1 

    Background: Various gene-expression signatures for breast cancer are available for the prediction of clinical outcome. However due to small overlap between different signatures, it is challenging to integrate existing disjoint signatures to provide a unified insight on the association between...

  • DNA Microarrays in Clinical Cancer Research. Wadlow, Raymond; Ramaswamy, Sridhar // Current Molecular Medicine;Feb2005, Vol. 5 Issue 1, p111 

    The recent sequencing of the human genome, coupled with advances in biotechnology, is enabling the comprehensive molecular “profiling” of human tissues. In particular, DNA microarrays are powerful tools for obtaining global views of human tumor gene expression. Complex information...

  • Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. Peilin Jia; Yang Liu; Zhongming Zhao // BMC Systems Biology;2012, Vol. 6 Issue Suppl 3, p1 

    Background: Pathway analysis of large-scale omics data assists us with the examination of the cumulative effects of multiple functionally related genes, which are difficult to detect using the traditional single gene/marker analysis. So far, most of the genomic studies have been conducted in a...

  • Significance Analysis of Microarrays (SAM) Offers Clues to Differences Between the Genomes of Adult Philadelphia Positive ALL and the Lymphoid Blast Transformation of CML. Grace, Colin; Nacheva, Elisabeth P. // Cancer Informatics;2012, Issue 11, p173 

    Philadelphia positive malignant disorders are a clinically divergent group of leukemias. These include chronic myeloid leukemia (CML) and de novo acute Philadelphia positive (Ph(+)) leukemia of both myeloid, and lymphoid origin. Recent whole genome screening of Ph(+)ALL in both children and...

  • TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer. Xi Chen; Jiang Li; Gray, William H.; Lehmann, Brian D.; Bauer, Joshua A.; Yu Shyr; Pietenpol, Jennifer A. // Cancer Informatics;2012, Issue 11, p147 

    Motivation: Triple-negative breast cancer (TNBC) is a heterogeneous breast cancer group, and identification of molecular subtypes is essential for understanding the biological characteristics and clinical behaviors of TNBC as well as for developing personalized treatments. Based on 3,247 gene...

  • Using Semantic Web Technologies to Annotate and Align Microarray Designs. Szpakowski, Sebastian; McCusker, James; Krauthammer, Michael // Cancer Informatics;2009, Issue 7, p65 

    In this paper, we annotate and align two different gene expression microarray designs using the Genomic ELement Ontology (GELO). GELO is a new ontology that leverages an existing community resource, Sequence Ontology (SO), to create views of genomically-aligned data in a semantic web...

  • Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. Therese Sorlie; Yulei Wang; Chunlin Xiao; Hilde Johnsen; Bjorn Naume; Raymond R Samaha; Anne-Lise Borresen-Dale // BMC Genomics;2006, Vol. 7, p127 

    Background: Gene expression profiling has been used to define molecular phenotypes of complex diseases such as breast cancer. The luminal A and basal-like subtypes have been repeatedly identified and validated as the two main subtypes out of a total of five molecular subtypes of breast cancer....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics